Introduction to Behavioral Neuroscience · Emotion and Mood
Mood and Emotional Disorders Associated with Depression
On this page 9 sections
In 30 seconds
Everyone feels sad sometimes, but major depressive disorder (MDD) Mood disorder with persistent depressed mood and/or anhedonia plus associated symptoms causing functional impairment. Full entry → is different: a persistent mood state — lasting weeks to months — that colors nearly every part of a person's life and interferes with daily functioning. Depression is a disorder of mood, not of brief emotion: an emotion is a short-lived reaction to a specific event; a mood is a prolonged, diffuse state that persists even when circumstances change.
This topic connects earlier brain structures to clinical reality. Depression involves measurable changes in the same circuitry that generates emotion: altered amygdala reactivity, reduced prefrontal control, dysregulated stress systems, and disrupted reward processing. It also introduces the biological hypotheses — most famously the monoamine hypothesis The idea that depression involves reduced serotonin, norepinephrine, and/or dopamine signaling. Full entry → — that have guided research and treatment.
Why this matters
Depression is one of the most common and disabling health conditions worldwide, and it frequently coexists with anxiety, substance use, and chronic illness. Understanding its neurobiology replaces stigma with a brain-based explanation, explains why treatments take time to work, and clarifies the difference between normal sadness and a clinical disorder warranting professional care.
The college version
Core Concepts
Emotion, mood, and affect
Three terms get confused constantly. Emotion is a brief, intense, stimulus-bound reaction (fear at a sudden noise). Mood is a longer-lasting, less specific state (feeling low for weeks). Affect is the observable expression of emotion — the flat tone, the animated face. Depression is a mood disorder; clinicians assess affect separately because the two can disagree.
Clinical features of major depressive disorder
The commonly taught symptom picture of a depressive episode includes: persistent sad or empty mood; anhedonia Loss of interest or pleasure in activities once enjoyed. Full entry → — loss of interest or pleasure in activities once enjoyed; changes in sleep and appetite; low energy; difficulty concentrating; feelings of worthlessness or guilt; psychomotor slowing or agitation; and, in severe cases, thoughts of death or suicide. Two features separate an episode from ordinary sadness: duration (symptoms most of the day, nearly every day, for at least two weeks — commonly taught) and functional impairment (disrupted work, school, or relationships).
The monoamine hypothesis
The classic account proposes that depression is associated with reduced signaling of the monoamine neurotransmitters — serotonin (5-HT), norepinephrine (NE), and dopamine (DA). Historical support: reserpine, an early blood-pressure drug that depletes monoamine stores, produced depression-like states in some people; and the first effective antidepressants increased monoamine availability. Selective serotonin reuptake inhibitors (SSRIs) block the serotonin transporter (SERT), raising synaptic serotonin. The hypothesis is useful but incomplete: monoamine levels rise within hours, yet clinical improvement takes weeks, so the mechanism must involve slower adaptations — receptor changes, neuroplasticity, gene expression.
Stress, the HPA axis, and the body
Chronic stress is a well-established risk factor, and the body's stress system is dysregulated in many people with depression. The HPA axis Hypothalamus–pituitary–adrenal cascade releasing cortisol under stress. Full entry → (hypothalamus → pituitary → adrenal cortex) typically shows hyperactivity — elevated cortisol, impaired negative feedback — and prolonged cortisol exposure can damage hippocampal neurons and suppress neurogenesis, possibly explaining the hippocampal volume reduction commonly reported in imaging studies.
Brain circuitry in depression
Imaging studies commonly report: amygdala hyperactivity to negative stimuli (the alarm rings too loud); reduced prefrontal activity, especially left dorsolateral PFC (the brake is weak); blunted reward-circuit activity in the ventral striatum (pleasure fades — the neural correlate of anhedonia); and altered default mode network activity linked to self-focused negative thought. Depression, in this view, is an imbalance: overactive subcortical alarm systems plus underactive cortical control.
Genetics and individual risk
Family and twin studies commonly estimate the heritability of major depression at roughly 30–40% (a commonly taught approximation). Gene–environment interactions matter: the same stressful event produces depression in some people but not others, partly because of genetic differences in stress reactivity. Early-life adversity, chronic stress, and prior episodes all raise risk. There is no single "depression gene" — depression is polygenic.
Bipolar disorder: the contrast case
bipolar disorder Mood disorder with depressive plus manic or hypomanic episodes. Full entry → involves episodes of depression and episodes of mania or hypomania — elevated, expansive, or irritable mood with increased energy, reduced need for sleep, grandiosity, and impulsivity. Depressive episodes in bipolar disorder can look identical to unipolar depression, so careful history-taking matters: treatments that help unipolar depression may not be appropriate for bipolar depression.
How It Works / Step-by-Step Process
Why an SSRI takes weeks to work:
- A person starts an SSRI; within hours the drug blocks SERT, so serotonin stays in the synaptic cleft longer.
- Synaptic serotonin rises quickly — yet mood does not change immediately.
- Over days to weeks, elevated serotonin drives adaptive changes: receptor downregulation, altered gene expression, enhanced neuroplasticity.
- Gradually, the prefrontal cortex regains regulatory strength, amygdala reactivity calms, and reward circuitry becomes more responsive.
- Clinical improvement typically appears after 2–6 weeks (a commonly taught window) — the therapeutic lag Delay of weeks between starting an antidepressant and clinical improvement. Full entry →.
- This is why antidepressants are not instant fixes and why medication decisions belong with a prescriber.
Common Confusions
| Common Confusion | With | Difference |
|---|---|---|
| Depression is just intense sadness. | MDD as a clinical syndrome | Sadness is normal; MDD requires persistent symptoms plus functional impairment over weeks. |
| Depression = "chemical imbalance," full stop. | A multifactorial disorder | Monoamine changes are part of the picture; stress biology, circuitry, genetics, and environment contribute too. |
| The monoamine hypothesis fully explains depression. | A useful but incomplete model | Monoamines rise quickly but improvement takes weeks, so slow adaptive mechanisms matter. |
| Bipolar depression is the same as unipolar depression. | Distinct disorders with overlapping episodes | Course and the presence of mania/hypomania differ. |
| SSRIs work within days. | Therapeutic lag | The commonly taught improvement window is 2–6 weeks. |
| A person with depression is "not trying hard enough." | A brain-based illness | Evidence shows altered circuitry, stress systems, and genetics — not laziness. |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Feeling sad for a day after something bad happens is normal. Depression is different: it's like a heavy, gray cloud that stays for weeks and makes everything — even games and favorite foods — feel flat and pointless. In the brain, the alarm part (amygdala) is too jumpy, the calm coach (prefrontal cortex) is too quiet, and the "happy chemicals" between brain cells aren't working normally. Depression is an illness of the brain, not a sign of weakness.
Worked example
Maya, a college student, recently lost her grandmother and failed a major exam. For a week she feels sad and tearful — but she still meets friends, laughs at a meme, and looks forward to pizza night. That is grief: a response to specific events that fades with time. Six months later, Maya has felt "flat" nearly every day: she skips class, no longer enjoys the gaming club she loved (anhedonia), sleeps 12 hours yet feels exhausted, and can't concentrate on a page. This persistence plus functional impairment — not just sadness — is what a clinician would explore as a possible depressive episode. Her brain story matches the textbook picture: an overactive amygdala, a quiet left PFC, and a blunted reward system that makes pizza night feel like nothing.
Key takeaways
- Emotion vs mood vs affect: brief reactive feeling vs prolonged state vs observable expression; depression is a mood disorder.
- Core symptoms: persistent low mood + anhedonia + sleep/appetite/energy/concentration changes + functional impairment, typically ≥2 weeks (commonly taught threshold).
- Monoamine hypothesis: reduced serotonin/norepinephrine/dopamine signaling; SSRIs block SERT; supported by reserpine findings but incomplete — therapeutic lag outlasts the immediate rise in monoamines.
- HPA axis hyperactivity (elevated cortisol, impaired feedback) links chronic stress to depression and hippocampal changes.
- Circuit picture: amygdala overactive, left PFC underactive, reward circuitry blunted (anhedonia).
- Heritability ≈ 30–40% (commonly taught approximation); depression is polygenic and interacts with environment.
- Bipolar disorder = depression + mania/hypomania — a key differential, not the same as unipolar depression.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Distinguish emotion, mood, and affect, and say which one depression is a disorder of.
Show answer
Emotion is brief, intense, and stimulus-bound; mood is a prolonged diffuse state; affect is the observable expression. Depression is a disorder of mood.
List four core symptoms of a major depressive episode and the two features separating it from ordinary sadness.
Show answer
Any four of: low mood, anhedonia, sleep change, appetite/weight change, low energy, poor concentration, guilt, psychomotor change, suicidal thoughts. Separating features: duration (nearly every day for ≥2 weeks — commonly taught) and functional impairment.
State the monoamine hypothesis with one supporting piece of evidence and one limitation.
Show answer
Depression involves reduced serotonin/norepinephrine/dopamine signaling. Support: reserpine could produce depressive states; SSRIs block SERT and raise serotonin. Limitation: monoamines rise within hours yet improvement takes weeks, so slow adaptive changes must be involved.
How does the HPA axis connect chronic stress to depression?
Show answer
Chronic stress drives HPA hyperactivity — elevated cortisol, impaired feedback — harming hippocampal neurons and neurogenesis, which contributes to the mood and memory changes seen in depression.
Describe the typical circuit picture in depression (amygdala, PFC, reward system).
Show answer
Amygdala overactive, left dorsolateral PFC underactive (weak regulation, rumination), reward circuitry (ventral striatum) blunted — the correlate of anhedonia.
Why distinguish unipolar from bipolar depression clinically?
Show answer
Because the two can present with identical depressive episodes but differ in course (mania/hypomania) and treatment considerations.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- major depressive disorder (MDD)
- Mood disorder with persistent depressed mood and/or anhedonia plus associated symptoms causing functional impairment.
- anhedonia
- Loss of interest or pleasure in activities once enjoyed.
- monoamine hypothesis
- The idea that depression involves reduced serotonin, norepinephrine, and/or dopamine signaling.
- selective serotonin reuptake inhibitor (SSRI)
- Drug that blocks the serotonin transporter (SERT), raising synaptic serotonin.
- HPA axis
- Hypothalamus–pituitary–adrenal cascade releasing cortisol under stress.
- bipolar disorder
- Mood disorder with depressive plus manic or hypomanic episodes.
- therapeutic lag
- Delay of weeks between starting an antidepressant and clinical improvement.
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.